Lund, Sweden

Dick Heinegård

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Dick Heinegård

Introduction

Dick Heinegård is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of diagnostics, particularly in relation to collagen and cartilage-related proteins. With a total of 4 patents, his work has advanced the understanding and detection of various medical conditions.

Latest Patents

Heinegård's latest patents include a method for diagnosing collagen IX destruction. This innovative method allows for the detection or monitoring of protein fragments cleaved at novel sites near the N-terminal part of the collagen IX alpha 1 chain. Additionally, he has developed neoepitope antibodies against these cleavages, which are unique to collagen IX. Another significant patent involves monoclonal antibodies for cartilage oligomeric matrix protein (COMP). This invention provides a sensitive direct sandwich assay for determining the presence of COMP in clinical samples, utilizing two monoclonal antibodies directed against separate antigenic determinants of the COMP molecules.

Career Highlights

Throughout his career, Dick Heinegård has worked with various companies, including Anamar AB and Anamar Medical AB. His contributions have been instrumental in the development of diagnostic kits and antibodies that are crucial for medical research and clinical applications.

Collaborations

Heinegård has collaborated with notable individuals in his field, including Mikael Danfelter and Patrik Önnerfjord. These collaborations have further enhanced the impact of his inventions and research.

Conclusion

Dick Heinegård's innovative work in the field of diagnostics has led to significant advancements in the detection of collagen and cartilage-related proteins. His contributions continue to influence medical research and clinical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…